Alvotech share price logo

Alvotech

NASDAQ: ALVO

Small Cap

$5.36

+0.02

(+0.28%)

Live

as on

Alvotech Stock Performance

as on September 4, 2026 at 5:22 am IST

  • Day's Low

    Day's High

    $5.28
    $5.46
    downward going graph

    1.49%

    Downside

    1.87%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.94
    $9.25
    downward going graph

    45.15%

    Downside

    72.57%

    Upside

    downward going graph

Alvotech share price movements today

Previous Close
$5.34
Open
$5.44
Volume
559.8K
Market Cap
$1.9B
Day's Low - High
$5.28 - $5.46
52 Week Low - High
$2.94 - $9.25

Alvotech Historical Returns

1 Month Return
+ 27.18 %
3 Month Return
+ 74.67 %
1 Year Return
-34.09 %
3 Year Return
-47.28 %
5 Year Return
0 %

Alvotech Stock Fundamentals & Key Indicators

Check Alvotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

-0.0181

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.99%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

75.7M

Revenue (TTM)

494.6M

Profit Margin

-36.31%

Return On Equity TTM

0.00%

Alvotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alvotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Alvotech image
Alvotech
BUY$1.9BNANA-36.31%NA
United Therapeutics image
United Therapeutics
BUY$22.0B141.49%16.5886.14%NA
Viatris image
Viatris
HOLD$19.0B9.91%-46.4434.83%2.87%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
BUY$44.4BNA20.4714.55%121.78%
Zoetis image
Zoetis
BUY$31.9B-63.08%12.4770.87%2.76%
See all

Stock Returns calculator for Alvotech Stock including INR - Dollar returns

The Alvotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Alvotech investment value today

Current value as on today

₹72,322

Returns

-₹27,678

(-27.68%)

Returns from Alvotech Stock

-₹32,579 (-32.58%)

Dollar Impact

₹4,901 (+4.9%)

Analyst Recommendation on Alvotech Stock

Based on 3 analysts

BUY

66.67%

Buy

0.00%

Hold

33.33%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Alvotech. Average target price of $6

Alvotech Share Price Target

Get share price movements and forecasts by analysts on Alvotech.

What analysts predicted

10.67%UPSIDE

Target Price

$6

Current Price

$5.36

Analyzed by

3 Analysts

Target

$6.00

Alvotech target price $6, a slight upside of 10.67% compared to current price of $5.36. According to 3 analysts rating.

Indian Investors' Interest in Alvotech Stock

Search interest for Alvotech Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:22% versus previous 30 day period

Alvotech Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
36
198
102
151
132
173
113
166
105
105
Gross Profit
16
153
63
70
67
99
78
105
59
53
Operating Income
-48
91
12
13
10
18
1
48
9
-11
EBITDA
-33
-16
138
-119
137
51
32
-84
52
-1
Interest Expense
184
42
90
159
35
36
36
40
40
41
Depreciation
7
7
8
8
8
8
10
10
10
-
Income Before Tax
-225
76
-24
-44
93
9
-6
39
0
-66
Income Tax Expense
-6
11
-13
22
-16
-22
0
148
0
0
Net Income
-218
65
-11
-66
109
32
-5
-108
1
-66
Net Profit Margin
-593.53%
32.82%
-11.07%
-44.29%
82.61%
18.49%
-4.58%
-65.27%
0.97%
-63.17%

Alvotech Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
31
66
36
83
91
489
586
Gross Profit
31
66
36
18
-69
304
350
Operating Income
-61
-137
-235
-346
-354
69
78
EBITDA
-99
-177
-18
-439
-493
-32
323
Interest Expense
95
97
112
91
134
157
149
Depreciation
14
16
18
20
24
31
37
Income Before Tax
-209
-291
-149
-551
-651
-217
136
Income Tax Expense
0
-121
-47
-38
-99
14
108
Net Income
-209
-170
-101
-513
-551
-231
27
Net Profit Margin
-657.55%
-255.26%
-276.04%
-618.55%
-603.42%
-47.35%
4.76%

Alvotech Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
65
-11
-66
109
32
-5
-108
1
-66
Operating Cash Flow
-50
-71
-39
12
55
-55
-62
-60
-19
Investing Cash Flow
-7
22
-31
-20
-28
-39
-15
-46
-44
Financing Cash Flow
4
155
4
-5
83
-13
206
0
143
Change in Cash
-53
107
-66
-12
112
-108
129
-108
78

Alvotech Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-170
-101
-513
-551
-231
27
Operating Cash Flow
-74
-228
-312
-312
-236
-50
Investing Cash Flow
-16
-40
-63
-46
-18
-104
Financing Cash Flow
55
254
424
301
297
270
Change in Cash
-35
-14
48
-55
40
120

Mutual Funds that own Alvotech Stock

Check out the Mutual Funds with significant holdings in Alvotech.

Funds
Holdings
Shares Held
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
0.466802%
1822544
VANGUARD STAR FUNDS
0.400187%
1562460
T. ROWE PRICE INTERNATIONAL FUNDS, INC.
0.28696%
1120386
Fidelity Concord Street Trust
0.045687%
178379
Eaton Vance Mutual Funds Trust
0.017083%
66700
See all

Global Institutional Holdings in Alvotech

Funds
Holdings
Andrew J.M. Spokes
0.73%
iShares
0.46%
Chuck Royce
0.14%
Fidelity
0.03%
Invesco
0.02%
See all

Alvotech News & Key Events

  • img

    Today's Timeline - 31 August

    Mon, 05:30 PM

    -

    FDA accepts Alvotech's BLA for AVT80, a biosimilar to Entyvio, marking a significant milestone for the company's biosimilar program.

Insights on Alvotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ALVO stock has moved up by 9.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation Common Stock has given 58.4% return, outperforming this stock by 104.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 62.0% return, outperforming this stock by 94.8%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 166.36M → 105.77M (in $), with an average decrease of 18.2% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 1.03M → -66.82M (in $), with an average decrease of 6587.5% per quarter

About Alvotech

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company provides AVT02, a high concentration, low-volume adalimumab formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ankylosing spondylitis ulcerative colitis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. In addition, it offers AVT05, a biosimilar to Simponi and Simponi Aria to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT16, a biosimilar to an Entyvio product for the treatment of adult patients with moderate to severe ulcerative colitis and moderate to severely active Crohn's disease; AVT23, a biosimilar to Xolair to treat allergic asthma, chronic spontaneous urticaria (CSU), and nasal polyp; and AVT33, a biosimilar to Keytruda product which is in early phase development. Alvotech was founded in 2013 and is based in Luxembourg, Luxembourg.
OrganisationAlvotech
Headquarters9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273
IndustryDrug Manufacturers - Specialty & Generic
CEOMs. Lisa Graver
E-voting on sharesClick here to vote

Key Management of Alvotech

Name

Title

Mr. Joseph E. McClellan

Chief Operating Officer

Ms. Sarah Macleod

Head of Global Communications

Ms. Kathryn Gunnarsson

Senior Vice President of Global Talent & People Experience

Mr. Anthony M. Maffia III

Chief Quality & Regulatory Officer

Mr. Vilhelm Robert Wessman

Founder & Executive Chairman

Ms. Lisa Graver

Chief Executive Officer

Ms. Linda Jonsdottir

Chief Financial Officer

Ms. Neha Patel

Chief Information Officer

Mr. Benedikt Stefansson

Vice President of Investor Relations & Global Communications

Dr. Balaji Venkataramanan Prasad M.D.

Chief Strategy Officer

FAQs

What is Alvotech share price today?

Alvotech share price today is $5.36 as on . Alvotech share today touched a day high of $5.46 and a low of $5.28.

What is the 52 week high and 52 week low for Alvotech share?

Alvotech share touched a 52 week high of $9.25 on and a 52 week low of $2.94 on . Alvotech stock price today i.e. is trending at $5.36,which is 42.05% down from its 52 week high and 82.31% up from its 52 week low.

What is Alvotech's market capitalisation today?

Alvotech market capitalisation is $0.00T as on .

How to invest in Alvotech Stock (ALVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alvotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alvotech Shares that will get you 0.2799 shares as per Alvotech share price of $5.36 per share as on September 3, 2026 at 11:52 pm IST.

What is the minimum amount required to buy Alvotech Stock (ALVO) from India?

Indian investors can start investing in Alvotech (ALVO) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Alvotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Alvotech share’s latest price of $5.36 as on September 3, 2026 at 11:52 pm IST, you will get 1.8657 shares of Alvotech. Learn more about fractional shares .